Search research articles
Contact Us
Filters
Showing results (21-30 of 97) with videos related to
Page
of 10
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
July 16, 2018
Evidence for and Against Green Tea and Turmeric in the Management of Chronic Lymphocytic Leukemia
Erin Bange, Colleen Timlin, Charlene Kabel, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 23, 2017
Chimeric Antigen Receptor T-Cell Therapy for Chronic Lymphocytic Leukemia: A Narrative Review
Anthony R Mato, Meghan C Thompson, Chadi Nabhan, et al.
Cancer Biology & Therapy
|
March 28, 2018
Drivers of treatment patterns in patients with chronic lymphocytic leukemia stopping ibrutinib or idelalisib therapies
Anthony R Mato, Jennifer C Samp, Geneviève Gauthier, et al.
Therapeutic Advances in Hematology
|
June 24, 2022
The potential of pirtobrutinib in multiple B-cell malignancies
Jeffrey L Jensen, Anthony R Mato, Camila Pena, et al.
British Journal of Haematology
|
June 10, 2026
Evolution of the drug sensitivity landscape of chronic lymphocytic leukaemia
Johanne U Hermansen, Yanping Yin, Geir E Tjønnfjord, et al.
American Journal of Hematology
|
September 20, 2022
Approach to a patient with "double refractory" chronic lymphocytic leukemia: "Double, double toil and trouble" (Shakespeare)
Julia H Aronson, Sigrid S Skånland, Lindsey E Roeker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2025
Protein Profiles Predict Treatment Responses to the PI3K Inhibitor Umbralisib in Patients with Chronic Lymphocytic Leukemia
Yanping Yin, Haifeng Xu, Liye He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2020
BTK Inhibitors in Cancer Patients with COVID-19: "The Winner Will be the One Who Controls That Chaos" (Napoleon Bonaparte)
Elise A Chong, Lindsey E Roeker, Mazyar Shadman, et al.
Leukemia & Lymphoma
|
October 3, 2018
Adverse events, resource use, and economic burden associated with mantle cell lymphoma: a real-world assessment of privately insured patients in the United States
Ravi K Goyal, Saurabh P Nagar, Shaum M Kabadi, et al.
Hemasphere
|
December 26, 2022
COVID-19 Vaccination Response and Its Practical Application in Patients With Chronic Lymphocytic Leukemia
Mazyar Shadman, Catherine Liu, Katherine Eakle, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 97) with videos related to
Sort By:
Page
of 10
Clinical Lymphoma, Myeloma & Leukemia
|
July 16, 2018
Evidence for and Against Green Tea and Turmeric in the Management of Chronic Lymphocytic Leukemia
Erin Bange, Colleen Timlin, Charlene Kabel, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 23, 2017
Chimeric Antigen Receptor T-Cell Therapy for Chronic Lymphocytic Leukemia: A Narrative Review
Anthony R Mato, Meghan C Thompson, Chadi Nabhan, et al.
Cancer Biology & Therapy
|
March 28, 2018
Drivers of treatment patterns in patients with chronic lymphocytic leukemia stopping ibrutinib or idelalisib therapies
Anthony R Mato, Jennifer C Samp, Geneviève Gauthier, et al.
Therapeutic Advances in Hematology
|
June 24, 2022
The potential of pirtobrutinib in multiple B-cell malignancies
Jeffrey L Jensen, Anthony R Mato, Camila Pena, et al.
British Journal of Haematology
|
June 10, 2026
Evolution of the drug sensitivity landscape of chronic lymphocytic leukaemia
Johanne U Hermansen, Yanping Yin, Geir E Tjønnfjord, et al.
American Journal of Hematology
|
September 20, 2022
Approach to a patient with "double refractory" chronic lymphocytic leukemia: "Double, double toil and trouble" (Shakespeare)
Julia H Aronson, Sigrid S Skånland, Lindsey E Roeker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2025
Protein Profiles Predict Treatment Responses to the PI3K Inhibitor Umbralisib in Patients with Chronic Lymphocytic Leukemia
Yanping Yin, Haifeng Xu, Liye He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2020
BTK Inhibitors in Cancer Patients with COVID-19: "The Winner Will be the One Who Controls That Chaos" (Napoleon Bonaparte)
Elise A Chong, Lindsey E Roeker, Mazyar Shadman, et al.
Leukemia & Lymphoma
|
October 3, 2018
Adverse events, resource use, and economic burden associated with mantle cell lymphoma: a real-world assessment of privately insured patients in the United States
Ravi K Goyal, Saurabh P Nagar, Shaum M Kabadi, et al.
Hemasphere
|
December 26, 2022
COVID-19 Vaccination Response and Its Practical Application in Patients With Chronic Lymphocytic Leukemia
Mazyar Shadman, Catherine Liu, Katherine Eakle, et al.
Page
of 10